Zurich Cantonal Bank
ATRS

Zurich Cantonal Bank’s Antares Pharma, Inc. ATRS Stock Holding History

Zurich Cantonal Bank’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-51,395
Closed -$211K – 2968
2022
Q1 		$211K Hold
51,395
– – ﹤0.01% 1850
2021
Q4 		$183K Buy
51,395
+40,140
+357% +$140K ﹤0.01% 2124
2021
Q3 		$41K Hold
11,255
– – ﹤0.01% 2681
2021
Q2 		$49K Hold
11,255
– – ﹤0.01% 2455
2021
Q1 		$46K Hold
11,255
– – ﹤0.01% 2411
2020
Q4 		$45K Hold
11,255
– – ﹤0.01% 2464
2020
Q3 		$30K Hold
11,255
– – ﹤0.01% 2406
2020
Q2 		$31K Hold
11,255
– – ﹤0.01% 2358
2020
Q1 		$27K Hold
11,255
– – ﹤0.01% 2252
2019
Q4 		$53K Hold
11,255
– – ﹤0.01% 2115
2019
Q3 		$38K Hold
11,255
– – ﹤0.01% 2208
2019
Q2 		$37K Hold
11,255
– – ﹤0.01% 2239
2019
Q1 		$34K Hold
11,255
– – ﹤0.01% 2217
2018
Q4 		$31K Buy
+11,255
New +$37.1K ﹤0.01% 2289

Other funds holding ATRS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Zurich Cantonal Bank's ATRS Position: Q2 2022 in Review

Zurich Cantonal Bank sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 51,395 shares — an estimated $211K sold.

Zurich Cantonal Bank first reported a position in ATRS in Q4 2018 and held it in 14 quarters. The position peaked at $211K in Q1 2022. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

  • Zurich Cantonal Bank reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
  • Zurich Cantonal Bank sold 51,395 Antares Pharma, Inc. shares in Q2 2022, an estimated $211K.
  • Zurich Cantonal Bank first reported a position in Antares Pharma, Inc. in Q4 2018 and held it in 14 quarters.
  • Zurich Cantonal Bank's Antares Pharma, Inc. position peaked at $211K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Zurich Cantonal Bank's 13F filing for Q2 2022, filed 9 Aug 2022.